Global Pressurized Metered-dose Inhaler Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pressurized Metered-dose Inhaler Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Pressurized Metered-dose Inhaler market size was valued at USD 6205.4 million in 2023 and is forecast to a readjusted size of USD 7535.7 million by 2030 with a CAGR of 2.8% during review period.

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.

Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.

North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.

Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

The Global Info Research report includes an overview of the development of the Pressurized Metered-dose Inhaler industry chain, the market status of Hospitals (Single-dose Inhalers, Multi-dose Inhalers), Ambulatory Surgery Centres (Single-dose Inhalers, Multi-dose Inhalers), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pressurized Metered-dose Inhaler.

Regionally, the report analyzes the Pressurized Metered-dose Inhaler markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pressurized Metered-dose Inhaler market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Pressurized Metered-dose Inhaler market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pressurized Metered-dose Inhaler industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Single-dose Inhalers, Multi-dose Inhalers).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pressurized Metered-dose Inhaler market.

Regional Analysis: The report involves examining the Pressurized Metered-dose Inhaler market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pressurized Metered-dose Inhaler market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Pressurized Metered-dose Inhaler:

Company Analysis: Report covers individual Pressurized Metered-dose Inhaler manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pressurized Metered-dose Inhaler This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgery Centres).

Technology Analysis: Report covers specific technologies relevant to Pressurized Metered-dose Inhaler. It assesses the current state, advancements, and potential future developments in Pressurized Metered-dose Inhaler areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pressurized Metered-dose Inhaler market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Pressurized Metered-dose Inhaler market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Single-dose Inhalers
Multi-dose Inhalers

Market segment by Application
Hospitals
Ambulatory Surgery Centres

Major players covered
Glenmark Pharmaceuticals(India)
Novartis International AG(Switzerland)
Propeller Health(USA)
AstraZeneca Plc(Sweden)
Philips Respironics(Netherlands)
Teva Pharmaceutical Industries(Israel)
Opko Health(USA)
Merck(USA)
BioCare Group(Malaysia)

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pressurized Metered-dose Inhaler product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pressurized Metered-dose Inhaler, with price, sales, revenue and global market share of Pressurized Metered-dose Inhaler from 2019 to 2024.

Chapter 3, the Pressurized Metered-dose Inhaler competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pressurized Metered-dose Inhaler breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pressurized Metered-dose Inhaler market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pressurized Metered-dose Inhaler.

Chapter 14 and 15, to describe Pressurized Metered-dose Inhaler sales channel, distributors, customers, research findings and conclusion.